Explore the revolutionary potential of biotechnology and gene editing, alongside crucial ethical considerations and ...
Highly sensitive next-generation sequencing-based MRD testing will identify eligible patients with T-cell malignancies ...
Verified Investing on MSN
My trading game plan revealed - 07/06/2026: S&P 500 line in the sand, chip sell-off, biotech rotation and yen carry risk
Gareth Soloway's technical market breakdown: S&P 500 trend-line test, semiconductor unwind, AI-to-biotech rotation, USD/JPY ...
Healthcare veteran Dr Douglas Williams discusses the impact of recent political upheaval in the US and the prospect of major ...
The Russell Microcap Index has more than doubled the performance of the S&P 500 this year . Microcap stocks as a group have soared this year. That comes with ...
Researchers at the University of Bayreuth and Forschungszentrum Jülich have demonstrated that specific light-sensitive ...
Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
ATUM, a leading US-based contract research organization, selected to support stable clonal cell line generation to advance VERAXA’s lead BiTAC-TCE program toward IND/CTA-enabling activities ...
French pharma Ipsen is continuing to expand its product portfolio via M&A deals, today announcing plans to acquire privately-owned Swiss biotech Memo Therapeutics.
This cell-like structure can grow, feed, divide and compete. Researchers ponder what it means for the future of synthetic ...
At an event for pharmaceutical executives, biotech founders, and researchers on Tuesday, Anthropic announced Claude Science, ...
Over the past several years, we have seen accelerating technological change. Machine learning is accelerating drug discovery, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results